Congratulations Aadit Palicha, Kaivalya V. and the team at Zepto on an important milestone. Honoured to be partners since inception. Suvir Sujan 🔗 https://lnkd.in/gwv8zrpw
Nexus Venture Partners’ Post
More Relevant Posts
-
“In The Age of AI, Everything is an API!" Watch Postman Co-Founder & CEO Abhinav Asthana and Nexus Venture Partners MD Jishnu B. in an exclusive conversation with Shereen Bhan, Managing Editor, CNBC-TV18. https://lnkd.in/gymvTRRm
The Moonshot Opportunity For India's Most-Valued SaaS Unicorn | Young Turks: Voices From The Valley
https://www.youtube.com/
To view or add a comment, sign in
-
We're delighted to co-lead Rocketlane's Series B, deepening our partnership with this B2B SaaS leader! The phenomenal team is ready to transform client project delivery with its powerful AI-first roadmap while serving a rapidly growing customer base worldwide. Huge congrats to Srikrishnan Ganesan, Vignesh Girishankar, Deepak Bala, and the entire team! Jishnu B., Sameer Brij Verma, Arjun Gandhi https://lnkd.in/gsq7ShsW
Nexus co-leads Series B in partner company Rocketlane
economictimes.indiatimes.com
To view or add a comment, sign in
-
We are thrilled to continue backing the Iambic team led by Thomas Miller and Fred Manby. Iambic Therapeutics is making a remarkable impact at the intersection of AI and medicine. “Iambic’s novel generative AI platform for drug development with demonstrated ability to discover drug molecules and advance them to clinical trials is unmatched in the industry," said Jishnu B., MD, Nexus, as he expressed his confidence in Iambic's journey ahead. Congratulations to Iambic on closing the latest funding round! https://lnkd.in/eQk6jD96
Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs
iambic.ai
To view or add a comment, sign in
-
Founded in a lab at Indian Institute of Technology, Bombay, we are thrilled to have been early partners with SEDEMAC and to watch the company build a Global IP from India. Shashikanth Suryanarayanan | Amit Dixit | Manish Sharma | Sandeep Singhal 🔗 https://lnkd.in/daknEcrJ
Building a Global IP from India ft. Sedemac
https://www.youtube.com/
To view or add a comment, sign in
-
Puneet Kumar just joined the team, and we're stoked to have him on board! Join us in welcoming him.
Venture Partner at Nexus, Prev Visiting Partner at YC, Founder & CEO at SuprDaily (scaled to $100M annual revenue run rate, exited to Swiggy). 2x Founder. Alumnus of IIT Bombay.
Excited to join Nexus Venture Partners as a Venture Partner and pay it forward to the startup ecosystem. After building multiple startups and investing in companies globally as part of Y Combinator, I am eager to partner with and learn from the next wave of entrepreneurs. Looking forward to work alongside Suvir Sujan, Jishnu B., Anup Gupta, Abhishek Sharma, Pratik Poddar, Anand Datta, and our offices in India and the US. If you are building something or thinking about it, please reach out. I love talking to founders and learning about new spaces. Please drop a note at puneet@nexusvp.com.
This content isn’t available here
Access this content and more in the LinkedIn app
To view or add a comment, sign in
-
We're thrilled to welcome Triomics, a novel Generative AI platform dedicated to empowering cancer care providers, to the Nexus family! Triomics leverages their proprietary OncoLLM™ models, to unlock the power of unstructured medical data in patient records. This translates to: → Faster analysis of vast amounts of free-text data → Efficient matching of patients to potentially life-saving clinical trials → Streamlined care operations for improved quality and efficiency → Precision oncology: delivering the right treatments to the right patients Their impressive early results and collaborations with leading cancer centers position Triomics to make a significant global impact in the fight against cancer. We're incredibly proud to partner with Sarim Khan and Hrituraj Singh, the brilliant minds behind Triomics, and support them in building a company that will truly change lives. Jishnu B. https://lnkd.in/gjytiJkg
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch
https://techcrunch.com
To view or add a comment, sign in
64,853 followers
Financial Analyst
3wNexus Venture Partners continues to impress by backing visionary new-age founders. Their commitment to nurturing innovation and driving growth in the startup ecosystem is commendable. Excited to see how their support will help shape the future of technology and entrepreneurship. Keep up the excellent work! I hope one day I will work with you guys...🤞